Company / Profit Margin
Amneal Pharmaceuticals, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
2.4%
FY2025
5-year range
-37.1% / 2.4%
FY2021-FY2025
Trend
+157.2%
vs FY2024
Sector context
#52 of 146
Health Care
What the data says
At 2.4%, Amneal Pharmaceuticals, Inc.'s profit margin ranks #52 of 146 in the Health Care sector. Profit Margin has fluctuated over the past 10 years, ranging from -37.1% in FY2021 to 2.4% in FY2025.
Based on SEC 10-K filings.
2.4% in FY2025 with a 5-year CAGR of +3.6%.
Improved from 0.6% to 2.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +14.6pp
- 5-Year Change
- +3.6pp
- 10-Year Change
- -
Sector benchmark
#52 of 146 in Health CareTop 36% of 146This company 2.4% Sector average -796.3%
▼
+100.3% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 157.2% year-over-year.
- Currently 798.7pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 2.4% | +157.2% |
| FY2024 | -4.2% | -763.5% |
| FY2023 | 0.6% | +105.2% |
| FY2022 | -12.2% | +67.0% |
| FY2021 | -37.1% | -3018.5% |
| FY2020 | -1.2% | - |
| FY2019 | 0.0% | - |
| FY2018 | 0.0% | - |
| FY2017 | 0.0% | - |
| FY2016 | 0.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026